DNA constructs encoding Bacillus thuringiensis toxins from strain A20
Recombinant DNA coding for an insecticidally active form of the Bacillus thuringiensis endotoxin which DNA is derived from the chromosome plasmids of the A20 strain of Bacillus thuringiensis. The recombinant genes may be of the 6.6, 5.3 or 4.5 types. Further discloses a truncated chimetic endotoxin-producing gene derived from the 5.3 and 4.5-type genes of strain A20.
Latest Imperial Chemical Industries PLC Patents:
This invention relates to recombinant DNA, and in particular to such DNA coding Bacillus thuringiensis endotoxin.
The organism Bacillus thuringiensis carries genes which encode protein endotoxins which are insecticidal to a variety of agronomically important insects. They are not however harmful to many benign insects, or to earthworms, birds, fish or mammals. These endotoxins are thus useful as agricultural insecticides, particularly against Lepidopteran pests. Bacillus thuringiensis strains have been used as agricultural insecticides for many years.
Recently, Bacillus thuringiensis endotoxin genes have been engineered into dicotyledonous plants and shown to confer protection against insect attack. The Bacillus thuringiensis kurstaki strain, A20, is the subject of our prior unpublished copending UK application No 8730132 filed 24 Dec. 1987. Strain A20 has been deposited at the National Collection of Industrial and Marine Bacteria (NCIMB) at Aberdeen, Scotland on 20 Oct. 1987 under the NCIMB Accession Number 12570. It is more active than the commonly used variety kurstaki strain, HD-1. Strain A20 carries three different, but highly related, endotoxin genes similar to those described in the scientific literature as 6.6-, 5.3-, and 4.5-type genes. The first two genes are carried in one or more copies on plasmids and also on the bacterial chromosome, while the 4.5- type gene is only found on the bacterial chromosome.
According to the present invention we provide recombinant DNA coding for an insecticidally active form of the Bacillus thuringiensis endotoxin which DNA is derived from the A20 strain of Bacillus thuringiensis. The source of the DNA maybe either the chromosome or a plasmid.
In a further aspect, our invention comprises recombinant DNA coding for an insecticidally-active form of the Bacillus thuringiensis endotoxin which is derived from a 6.6-type endotoxin gene carried on a plasmid harboured by strain A20. The maximum molecular weight of such endotoxins is about 103,000 Dalton.
We have made such recombinant DNA comprising the first 2910 basepairs (970 amino acid codons) of the N-terminal coding region of a plasmid-derived 6.6-type endotoxin gene from Strain A20. The 6.6-type construct we have made encodes a fusion protein that includes 28 amino acid codons derived from the pUC19 vector DNA. The Bacillus thuringiensis-derived portion of the recombinant DNA has 10 basepair changes as compared with the analogous plasmid-derived 6.6-type gene from Bacillus thuringiensis strain HD 73 (Adang et al, Gene 36, 1985, 289-300). Surprisingly, all of the base changes occur within the generally conserved N-terminal portion of the gene previously designated as a "highly-conserved" region (Whiteley and Schnepf, Ann. Rev. Microbiol., 40, 1986, pp549-576). Nine of the ten changes are clustered in a 0.35 kilobase segment which does not overlap with any of the 5 regions shown to be conserved in all types of endotoxin genes analysed to date (Sanchis et al., Molecular Microbiol., 3, 1989, pp229- 238). Four of the 10 base changes result in amino acid substitutions.
The invention further comprises recombinant DNA coding for an insecticidally-active form of the Bacillus thuringiensis endotoxin which is derived from a 5.3-type endotoxin gene carried on a plasmid harboured by strain A20. The maximum molecular weight of the endotoxin is about 78,000 Daltons.
We have made such recombinant DNA comprising the first 2161 basepairs (696 amino acid codons) of the N-terminal coding region of a plasmid-derived 5.3-type endotoxin gene from Strain A20. This endotoxin gene differs from the analogous plasmid-derived 5.3-type gene from Bacillus thuringiensis strain HD-1 (Geiser etal., Gene 48, 1986, pp109-118) in that a deoxyguanosine base present in the published sequence at nucleotide 2024 is not present, resulting in a reading frame shift relative to the published structural gene. This frame shift results in a termination of the endotoxin gene product at amino acid residue 696, within the Bacillus thuringiensis-derived portion of the recombinant DNA. The recombinant DNA, however, encodes an insecticidally-active 5.3 type endotoxin protein.
In a further aspect, our invention comprises recombinant DNA coding for an insecticidally-active Bacillus thuringiensis endotoxin which is a chimera derived from sequences from at least two separate Bacillus thuringiensis genes. The molecular weight of the chimera may be of the order of 110,000 Daltons. Preferably the link or links between the sequences fall outside the hypervariable regions of such genes. In a more specific aspect, our invention comprises recombinant DNA coding for an insecticidally-active form of the Bacillus thuringiensis endotoxin comprising the first 1692 basepairs (564 amino acid codons) of the amino-terminal coding region from a 5.3-type endotoxin gene derived from Strain A20 and a restriction endonuclease Hind III-generated internal fragment of 1131 basepairs (377 amino acid codons) from a 4.5-type endotoxin gene derived from strain A20.
This chimetic gene encodes a novel fusion protein which also includes 28 amino acid codons derived from the pUC19 vector DNA. The Bacillus thuringiensis portion of the recombinant DNA has 97.1% DNA sequence homology with the 5.3-type gene from which it was largely derived. The internal Hind III-generated fragment used in the chimera and derived from the 4.5-type gene only differs from the analogous Hind III fragment from the 5.3-type gene by a 78 basepair insertion and 7 other physically separate base changes. These differences result in the in-frame addition of 26 amino acids due to the insertion, and in seven other amino acid changes; thus the novel protein has 91% amino acid homology with the 5.3-type gene product.
Recombinant genes according to our invention encoding insecticidally-active endotoxins may be of varying lengths. When cloning DNA from the A20 strain chromosome, it is convenient to use bacteriophage .lambda. vectors or other cloning vectors that sequester the recombinant DNA from host cell enzymes that might cause homologous recombination.
Three Escherichia coli strains containing the cloned 6.6- and 5.3-type endotoxin genes from A20 and the chimetic endotoxin gene have been deposited at the National Collection of Industrial and Marine Bacteria at Aberdeen, Scotland. These are:
______________________________________
NCIMB
Strain Accession
designation Endotoxin Protein
No.
______________________________________
E. coli MC1022/pJH1
5.3-type fusion protein
40049
E. coli MC1022/pJH2
Novel chimeric molecule
40050
E. coli MC1022/pJH10
6.6-type fusion protein
40211
______________________________________
The first two deposits were made on 23 Sep. 1988 and the third on 15 Sep. 1989.
The invention may be further understood by reference to the drawings, in which:
FIGS. 1A, 1B and 1C show diagramatically the structure of 6.6, 5.3 and chimetic-type genes, respectively as cloned;
FIG. 2 illustrates schematically the construction of pJH1 (=pIC49), pJH2(=pIC47) from publicly available vector pUC19 and DNA obtained from A20 (NCIMB 12570);
FIGS. 3A1, 3A2, 3A3, 3B1, 3B2, 3B3, 4A1, 4A2, 4A3, 4B1, 4B2, 4B3, 5A1, 5A2, 5A3, 5B1, 5B2 and 5B3 show the base sequence, the amino acid sequence and the main restriction sites of the pJH10 endotoxin gene;
FIGS. 6A1, 6A2, 6A3, 6B1, 6B2, 6B3, 7A1, 7A2, 7A3, 7B1, 7B2, 7B3, 8A1, 8A2, 8A3, 8B1 and 8B2 show the base sequence, the amino acid sequence and the main restriction sites of the pJH1 endotoxin gene;
FIGS. 9A1, 9A2, 9B1, 9B2, 10A1, 10A2, 10B1, 10B2, 11A1, 11A2, 11B1, 11B2, 12A1 and 12A2 show the base sequence, the amino acid sequence and the main restriction sites of the chimetic pJH2 endotoxin gene;
FIG. 13 shows the characteristics of the pJH10 endotoxin gene product;
FIG. 14 shows the characteristics of the pJH1 endotoxin gene product;
FIG. 15 shows the characteristics of the pJH2 endotoxin gene product.
With further reference to FIG. 1, in this diagram H represents HindIII, D=DraI, X=XmnI, C= ClaI, E=EcoR1, R=EcoRV, P=Ps+I, B=BclI and K =KpnI. A dot shows a base change, while x indicates a base change and amino acid substitution in the 6.6-type gene of the invention as compared with the 6.6-type gene of strain HD73. The line under the 6.6-type gene indicates the 2.2 kilobase DraI fragment sequenced, while the line under the 5.3-type gene indicates the approximate length of the coding sequence. The heavy broken line indicates vector DNA. In FIG. 2, H is again HindIII, while N represents NdeI.
With reference to FIGS. 5A1, 5A2, 5A3, 5B1, 5B2 and 5B3, it should be noted that the sequence from nucleotide 2228 to nucleotide 2907 (internal DraI to HindIII) has been taken from the published literature. All other sequence data given for constructs of the inventions has been obtained independently by us.
In Heliothis virescens bioassays the chimetic gene product is of comparable potency to that of the 5.3-type gene over the normal bioassay time-course of six days.
The preferred method of producing recombinant DNA according to the invention is by culturing a sample of deposited strains NCIMB 40049, 40050 or 40211, obtainable from the National Collection of Industrial and Marine Bacteria, under suitable conditions in appropriate media. Such conditions and media are well-known to the art. Variant forms of DNA according to the invention may be made by cloning suitable DNA sequences from bacteria of strain A20 (also deposited at the NCIMB, under No 12570).
The invention further comprises insecticidal compositions comprising Bacillus thuringiensis endotoxin produced by expression of recombinant DNA according to the invention: as well as a process of combating insects which comprises exposing them to effective amounts of such endotoxin.
Insecticidal compositions according to the invention may be obtained from cultured cell suspensions by appropriate lysis techniques. Preparations of lysed cells (i.e. cell extracts) may be used directly, or concentrated by lyophilisation, followed by reconstitution.
The process of the invention is generally carried out by incorporation of the nonviable cell extracts into, or onto, the insect food source. Alternatively the novel insecticidal gene can be introduced into the genome of food plants normally attacked by Lepidopteran pests. For this purpose suitable plant regulatory DNA sequences are inserted adjacent the recombinant DNA in operative relation therewith so as to allow expression of the endotoxin in the plant. Specific examples of commercially important plants to be protected in this manner are maize, cotton, and tobacco. Various plant transformation methods are known to the art, for example the use of Ti plasmid vectors (for dicots) protoplast regeneration, embryo microinjection and microprojectiles.
Insects which are combated by the invention include various Lepidopteran pests, for example, those in Table 1.
TABLE 1
______________________________________
COMMON NAME LATIN NAME
______________________________________
European Corn Borer
Ostrinia nubilalis
Tobacco Budworm Heliothis virescens
Tobacco Hornworm Manduca sexta
Corn Earworm Heliothis zea
Beet Armyworm Spodoptera exigua
Fall Armyworm Spodoptera frugiperda
Diamondback Moth Plutella xylostella
Cabbage Looper Trichoplusia ni
Eastern Spruce Budworm
Choristoneura fumiferana
Gypsy Moth Lymantria dispar
______________________________________
The following Examples illustrate the invention.
EXAMPLE 1Cloning of the plasmid-derived 6.6-type endotoxin gene carried on pJH10 and of chromosomally-derived endotoxin genes.
Covalently-closed circular (ccc) plasmid DNA was prepared from Bacillus thuringiensis Strain A20 (NCIMB 12570) by techniques well-known in the art. Large molecular weight (greater than 40 kilobases) plasmid ccc DNA was isolated by size fractionation on 10%-40% sucrose step gradients prior to digestion with restriction endonuclease Hind III and ligation into the Hind III--digested plasmid vector pUC19. The ligation reacted mixture was transformed into E. coli Strain MC1022, an ampicillin-sensitive strain with the genotype ara D139, .DELTA.(ara, leu) 7697, .DELTA.(lac Z) M15, gal U, gal K, str A. Amipicillin-resistant transformed colonies containing the 6.6 kilobase Hind III fragment were detected by hybridisation of lysed colonies fixed to nitrocellulose using a radioactively-labelled fragment of the Strain HD73 6.6-type endotoxin gene as a probe. Isolate pJH10 was further characterised by DNA hybridisation, restriction endonuclease mapping, and DNA sequence analysis techniques, all of which are well known in the art.
Endotoxin genes were cloned from chromosomal DNA prepared from Strain A20 (NCIMB 12570) as follows:
A 500 ml culture of Strain A20 was grown in L-broth at 37.degree. C., with shaking, until an O.D..sub.600 =1.00. Cells were harvested by centrifugation at 8000 rounds per minute (rpm) for 10 minutes at 4.degree. C., then re-suspended in 5 ml TES buffer (50 mM TriS-HCl pH7.5, 50mM NaCl, 5 mM EDTA). Cells were treated for 30 minutes at 37.degree. C. with lysozyme (0.5 mg/ml final concentration) and RNase (0.1 mg/ml final concentration taken from a stock solution of 5 mg/ml boiled at 100.degree. C for 5 minutes prior to use). Lysis was completed by the addition of Sarcosyl to give a final concentration of 0.8% and incubation at 37.degree. C. for 60 minutes in the presence of Pronase (0.5mg/ml final concentration taken from a stock solution of 5 mg/ml pre-incubated at 37.degree. C. for 60 minutes prior to use). Lysate volume was adjusted to 9.0 ml in the 50 mM Tris-HCl pH 7.6, 10 mM EDTA, prior to the addition of 9.2 g caesium chloride (CsCl). After the CsCl dissolved, 1.25 ml of a 5 mg/ml solution of ethidium bromide was added prior to isopyonic centrifugation of the mixture at 40,000 rpm for 48 hours at 15.degree. C.
After removal of CsCl and ethidium bromide by conventional techniques, an aliquot of purified chromosomal DNA was partially digested with the restriction endonuclease EcoR1 prior to ligation into EcoR1-digested bacteriophage .lambda. EMBL4 vector DNA. Ligation reaction mixtures were packaged into viable phage particles using a commercially-available kit from Amersham International PLC. The resultant recombinant phage particles were selected by growth on E. coli host strain PE392, a P2 lysogen of strain LE392 which has the genotype hsd R514 (r.sub.k.sup.-, M.sub.k.sup.+), sup E44, SUP F58, lacYl or .DELTA.(lac12Y), gal K2, gal T22, met B1, trp55. Recombinant phage carrying one or more endotoxin genes were detected by hybridisation of lysed plaques fixed to nitrocellulose using a radiolabelled fragment of the Strain A20 6.6-type plasmid-derived endotoxin gene as a probe.
Plaques containing endotoxin genes were purified and characterised by restriction endonuclease mapping techniques well known in the art.
EXAMPLE 2Construction of plasmid pJH2 containing the chimeric endotoxin gene.
DNA was prepared from plasmids pIC41 and pIC45, the derivation of which is shown in FIG. 2. pIC41 DNA was digested with restriction endonuclease HindIII and joined to the isolated, internal 1131 basepair HindIII-generated fragment from plasmid pIC45 using T4 DNA ligase. Methods for DNA preparation, DNA fragment purification and in vitro ligation reactions are all well known to the art. The ligation reaction mixture was introduced by transformation into E. coli strain MC1022, an F.sup.- strain with the genotype ara D139, .DELTA.(ara, leu) 7697, .DELTA.(lacZ) M15, galU, gal, str A. Ampicillin-resistant transformed colonies containing the 1131 basepair fragment were detected by hybridisation of lysed colonies fixed to nitrocellulose filters using the radioactively labelled 1131 basepair fragment as a probe. DNA samples from colonies reacting to the probe were checked for the presence of the introduced 1131 basepair fragment in the correct orientation. Transformation of E.coli cells made competent by treatment with calcium chloride, colony blotting, nick-translation of DNA to prepare radioactive probes, DNA hybridisation techniques, and restriction endonuclease "mapping" techniques are all well known in the art.
pJH1 was made in a similar manner from pIC34 and pIC41, as shown in FIG. 2.
EXAMPLE 3Preparation of insecticidal extracts according to the invention.
E.coli strain MC1022/pIC47 was grown in 400 ml Luria-broth supplemented with 50 .mu.g Ampicillin per ml overnight at 37 C. with shaking. Cells were harvested by centrifugation at 8000 rpm for 10 minutes at 4 C. and resuspended in 26.4 ml lysing buffer (150 mM NaCl, 20 mM Tris pH 8, 5 mM EDTA, 7 mM .beta.-mercaptoethanol). The resuspended cells were placed on ice and then 0.3 ml 0.1M phenylmethylsulphonylfluoride (PMSF) was added, followed by 3 ml of a freshly prepared solution of 10 mg lysozyme per ml, followed by a further addition of 0.3 ml PMSF. The mixture was left for 30 minutes on ice. The cell suspension was subjected to sonic disruption by treatment for 45 seconds with a one centimeter diameter sonicator probe operated at a frequency of 12 microns on an MSE Soniprep 150 sonifier. The sonicated sample was then centrifuged at 11000 rpm for 20 minutes at 4.degree. C. (using 50 cc capacity sterile centrifuge tubes). The supernatant was recovered by pouring off into a clean, sterile plastic container then dialyzed overnight at 4.degree. C. in 20 mM phosphate buffer (mono- and di-basic) pH 7.2. Insecticidal extracts can be stored frozen, or lyophilised and stored frozen.
EXAMPLE 4Efficacy of insecticidal extracts prepared from E.coli strains MC1022/pJH1 and MC1022/pJH2 in controlling Heliothis virescens and MC1022/pJH10 in controlling Heliothis virescens and Ostrinia nubilalis.
Insecticidal extract was added to molten insect diet (e.g. standard Heliothis diet) to give a final concentration of, for example, 1 ml per 10 g of diet (equivalent to approximately 510 ppm freeze-dried extract per treatment). 2.5 ml of treated diet was added to each of 10 plastic pots, covered and allowed to solidify. One first-instar larva was added to each pot and incubated at 27.degree. C. for six days, at which time the results were recorded. In tests with lower treatment concentrations (e.g. 0.1 ml extract per 10 g of diet), surviving larvae at six days were left for longer periods of observation to allow documentation of altered stability. Results of typical experiments are shown in Tables 2 and 3.
EXAMPLE 5Efficacy of insecticidal extracts prepared from strains MC1022/pJH2 and pJH1 on Lepidopteran larvae.
Lyophilised extracts from E.coli strains MC1022/pJB2 and MC1022/pdH1 were reconstituted in distilled water to give a stock solution which was then added, in varying amounts, to molten diet as described above in Example 4. Results of a typical bioassay experiment on Plutella xylostella (Diamondback moth, DBM), Heliothis zea (Corn earworm, CEW) and Trichoplusia ni (Cabbage looper, CL) are given in Table 4.
The work described herein was all done in conformity with physical and biological containment requirements specified in the NIH and GMAC guidelines.
TABLE 2
__________________________________________________________________________
Bioassay Results 6 Days After Treatment
Inhibition of Development
Percent
Larval
(number of larvae per stage)
Construct Plasmid
Mortality
Instar:
1 2E
2L
3E
3L
4
__________________________________________________________________________
Untreated controls
-- 0 5 2 8 4 1 --
5 -- --
3 4 4 5
Vector control
pUC19
0 -- 4 3 3 --
--
0 -- 2 --
4 2 2
Positive control
pIC18*
100 -- --
--
--
--
--
80 2 --
--
--
--
--
5.3-type endotoxin
pJH1 90 1 --
--
--
--
--
Chimeric endotoxin
pJH2 90 1 --
--
--
--
--
__________________________________________________________________________
*carries an endotoxin gene from B. thuringiensis HD73
E = early
L = late
TABLE 3
__________________________________________________________________________
Heliothis virescens and Ostrinia nubilalis Bioassay Results
Six Days after Treatment
H. virescens O. nubilalis
PERCENT LARVAL PERCENT LARVAL
GENE TYPE PLASMID
MORTALITY
SIZE* MORTALITY
SIZE*
__________________________________________________________________________
Untreated Controls
-- 0 2nd-4th instar
0 6.2 mm
Vector Control
pUC19 0 2nd-3rd instar
5 5.7 mm
Positive Control.sup.+
pIC18*
30 1st instar
50 2.0 mm
6.6 Type Gene
pJH10 50 1st instar
40 2.0 mm
__________________________________________________________________________
*Developmental stage or length of surviving larvae
.sup.+ Carries a 6.5 type endotoxin gene from B. thuringiensis strain HD7
TABLE 4
__________________________________________________________________________
% Mortality
% Stunting
Construct Plasmid
DBM CEW CL DBM CEW CL
__________________________________________________________________________
Untreated control
-- 0 0 0 0 0 0
Vector control
pUC19
0 0 0 0 0 0
Positive control
pIC18
100 5 0 0 95 100
5.3-type endotoxin
pJH1 95 0 0 5 100 45
Chimeric endotoxin
pJH2 100 5 0 0 95 65
__________________________________________________________________________
DEPOSIT OF MICROORGANISMS
The specification refers to four microorganisms that have been deposited. These are shown below. All four were deposited at the National Collections of Industrial and Marine Bacterial Limited (NCIMB) of PO BOX 31, 135 Abbey Road, Aberdeen, AB9 8DG, Scotland.
______________________________________
Strain NCIMB
designation Date of Deposit
Accession No.
______________________________________
Bacillus thuringiensis
20 Oct 1987 12570
kurstaki A20
E. coli MC1022/pJH1
23 Sep 1988 40049
E. coli MC1022/pJH2
23 Sep 1988 40050
E. coli MC1022/pJH10
15 Sep 1989 40211
______________________________________
The Bacillus thuringiensis strain A20 is fully described in our European Patent Publication no 325037, the disclosure of which is incorporated herein by reference. The three E. coli strains are of well known type, differing only in the plasmids they carry, full details of which are given elsewhere in the present specification.
__________________________________________________________________________
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(iii) NUMBER OF SEQUENCES: 6
(2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2990 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:
TATGTTT TAAATTGTAGTAATGAAAAACAGTATTATATCATAATGAATTGGTATCTTAAT60
AAAAGAGATGGAGGTAACTTATGGATAACAATCCGAACATCAATGAATGCATTCCTTATA120
ATTGTTTAAGTAACCCTGAAGTAGAAGTATTAGGTGGAGAAAGAATAGAAAC TGGTTACA180
CCCCAATCGATATTTCCTTGTCGCTAACGCAATTTCTTTTGAGTGAATTTGTTCCCGGTG240
CTGGATTTGTGTTAGGACTAGTTGATATAATATGGGGAATTTTTGGTCCCTCTCAATGGG300
ACGCATTTCTTGTACAAATTGAACAGTTAA TTAACCAAAGAATAGAAGAATTCGCTAGGA360
ACCAAGCCATTTCTAGATTAGAAGGACTAAGCAATCTTTATCAAATTTACGCAGAATCTT420
TTAGAGAGTGGGAAGCAGATCCTACTAATCCAGCATTAAGAGAAGAGATGCGTATTCAAT480
TCAATGA CATGAACAGTGCCCTTACAACCGCTATTCCTCTTTTGGCAGTTCAAAATTATC540
AAGTTCCTCTTTTATCAGTATATGTTCAAGCTGCAAATTTACATTTATCAGTTTTGAGAG600
ATGTTTCAGTGTTTGGACAAAGGTGGGGATTTGATGCCGCGACTATCAATAG TCGTTATA660
ATGATTTAACTAGGCTTATTGGCAACTATACAGATTATGCTGTACGCTGGTACAATACGG720
GATTAGAACGTGTATGGGGACCGGATTCTAGAGATTGGGTAAGGTATAATCAATTTAGAA780
GAGAATTAACACTAACTGTATTAGATATCG TTGCTCTGTTCCCGAATTATGATAGTAGAA840
GATATCCAATTCGAACAGTTTCCCAATTAACAAGAGAAATTTATACAAACCCAGTATTAG900
AAAATTTTGATGGTAGTTTTCGAGGCTCGGCTCAGGGCATAGAAAGAAGTATTAGGAGTC960
CACATTT GATGGATATACTTAACAGTATAACCATCTATACGGATGCTCATAGGGGTTATT1020
ATTATTGGTCAGGGCATCAAATAATGGCTTCTCCTGTCGGGTTTTCGGGGCCAGAATTCA1080
CGTTTCCGCTATATGGAACCATGGGAAATGCAGCTCCACAACAACGTATTGT TGCTCAAC1140
TAGGTCAGGGCGTGTATAGAACATTATCCTCTACTTTTTATAGAAGACCTTTTAATATAG1200
GGATAAATAATCAACAACTATCTGTTCTTGACGGGACAGAATTTGCTTATGGAACCTCCT1260
CAAATTTGCCATCCGCTGTATACAGAAAAA GCGGAACGGTAGATTCGCTGGATGAAATAC1320
CACCACAGAATAACAACGTGCCACCTAGGCAAGGATTTAGTCATCGATTAAGCCATGTTT1380
CAATGTTTCGTTCAGGCTCTAGTAGTAGTGTAAGTATAATAAGAGCTCCTATGTTCTCTT1440
GGATACA TCGTAGTGCTGAATTTAATAATATAATTGCATCGGATAGTATTACTCAAATCC1500
CTGCAGTGAAGGGAAACTTTCTTTTTAATGGTTCTGTAATTTCAGGACCAGGATTTACTG1560
GTGGGGACTTAGTTAGATTAAATAGTAGTGGAAATAACATTCAGAATAGAGG GTATATTG1620
AAGTTCCAATTCACTTCCCATCGACATCTACCAGATATCGAGTTCGTGTACGGTATGCTT1680
CTGTAACCCCGATTCACCTCAACGTTAATTGGGGTAATTCATCCATTTTTTCCAATACAG1740
TACCAGCTACAGCTACGTCATTAGATAATC TACAATCAAGTGATTTTGGTTATTTTGAAA1800
GTGCCAATGCTTTTACATCTTCATTAGGTAATATAGTAGGTGTTAGAAATTTTAGTGGGA1860
CTGCAGGAGTGATAATAGACAGATTTGAATTTATTCCAGTTACTGCAACACTCGAGGCTG1920
AATATAA TCTGGAAAGAGCGCAGAAGGCGGTGAATGCGCTGTTTACGTCTACAAACCAAC1980
TAGGGCTAAAAACAAATGTAACGGATTATCATATTGATCAAGTGTCCAATTTAGTTACGT2040
ATTTATCGGATGAATTTTGTCTGGATGAAAAGCGAGAATTGTCCGAGAAAGT CAAACATG2100
CGAAGCGACTCAGTGATGAACGCAATTTACTCCAAGATTCAAATTTCAAAGACATTAATA2160
GGCAACCAGAACGTGGGTGGGGCGGAAGTACAGGGATTACCATCCAAGGAGGGGATGACG2220
TATTTAAAGAAAATTACGTCACACTATCAG GTACCTTTGATGAGTGCTATCCAACATATT2280
TGTATCAAAAAATCGATGAATCAAAATTAAAAGCCTTTACCCGTTATCAATTAAGAGGGT2340
ATATCGAAGATAGTCAAGACTTAGAAATCTATTTAATTCGCTACAATGCAAAACATGAAA2400
CAGTAAA TGTGCCAGGTACGGGTTCCTTATGGCCGCTTTCAGCCCAAAGTCCAATCGGAA2460
AGTGTGGAGAGCCGAATCGATGCGCGCCACACCTTGAATGGAATCCTGACTTAGATTGTT2520
CGTGTAGGGATGGAGAAAAGTGTGCCCATCATTCGCATCATTTCTCCTTAGA CATTGATG2580
TAGGATGTACAGACTTAAATGAGGACCTAGGTGTATGGGTGATCTTTAAGATTAAGACGC2640
AAGATGGGCACGCAAGACTAGGGAATCTAGAGTTTCTCGAAGAGAAACCATTAGTAGGAG2700
AAGCGCTAGCTCGTGTGAAAAGAGCGGAGA AAAAATGGAGAGACAAACGTGAAAAATTGG2760
AATGGGAAACAAATATCGTTTATAAAGAGGCAAAAGAATCTGTAGATGCTTTATTTGTAA2820
ACTCTCAATATGATCAATTACAAGCGGATACGAATATTGCCATGATTCATGCGGCAGATA2880
AACGTGT TCATAGCATTCGAGAAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTG2940
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAA2990
(2) INFORMATION FOR SEQ ID NO:2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2815 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
AAATTGTAGTAATGAAAAACAGTATTATATCATAATGAATTGGTATCTTAATAAAAGAGA60
TGGAGGTAACTTATGGATAACAATCCGAACATCAATGAATGCATTCCTTA TAATTGTTTA120
AGTAACCCTGAAGTAGAAGTATTAGGTGGAGAAAGAATAGAAACTGGTTACACCCCAATC180
GATATTTCCTTGTCGCTAACGCAATTTCTTTTGAGTGAATTTGTTCCCGGTGCTGGATTT240
GTGTTAGGACTAGTTGATATAATATGGG GAATTTTTGGTCCCTCTCAATGGGACGCATTT300
CTTGTACAAATTGAACAGTTAATTAACCAAAGAATAGAAGAATTCGCTAGGAACCAAGCC360
ATTTCTAGATTAGAAGGACTAAGCAATCTTTATCAAATTTACGCAGAATCTTTTAGAGAG420
TGGGA AGCAGATCCTACTAATCCAGCATTAAGAGAAGAGATGCGTATTCAATTCAATGAC480
ATGAACAGTGCCCTTACAACCGCTATTCCTCTTTTTGCAGTTCAAAATTATCAAGTTCCT540
CTTTTATCAGTATATGTTCAAGCTGCAAATTTACATTTATCAGTTTTGAG AGATGTTTCA600
GTGTTTGGACAAAGGTGGGGATTTGATGCCGCGACTATCAATAGTCGTTATAATGATTTA660
ACTAGGCTTATTGGCAACTATACAGATCATGCTGTACGCTGGTACAATACGGGATTAGAG720
CGTGTATGGGGACCGGATTCTAGAGATT GGATAAGATATAATCAATTTAGAAGAGAATTA780
ACACTAACTGTATTAGATATCGTTTCTCTATTTCCGAACTATGATAGTAGAACGTATCCA840
ATTCGAACAGTTTCCCAATTAACAAGAGAAATTTATACAAACCCAGTATTAGAAAATTTT900
GATGG TAGTTTTCGAGGCTCGGCTCAGGGCATAGAAGGAAGTATTAGGAGTCCACATTTG960
ATGGATATACTTAACAGTATAACCATCTATACGGATGCTCATAGAGGAGAATATTATTGG1020
TCAGGGCATCAAATAATGGCTTCTCCTGTAGGGTTTTCGGGGCCAGAATT CACTTTTCCG1080
CTATATGGAACTATGGGAAATGCAGCTCCACAACAACGTATTGTTGCTCAACTAGGTCAG1140
GGCGTGTATAGAACATTATCGTCCACTTTATATAGAAGACCTTTTAATATAGGGATAAAT1200
AATCAACAACTATCTGTTCTTGACGGGA CAGAATTTGCTTATGGAACCTCCTCAAATTTG1260
CCATCCGCTGTATACAGAAAAAGCGGAACGGTAGATTCGCTGGATGAAATACCGCCACAG1320
AATAACAACGTGCCACCTAGGCAAGGATTTAGTCATCGATTAAGCCATGTTTCAATGTTT1380
CGTTC AGGCTTTAGTAATAGTAGTGTAAGTATAATAAGAGCTCCTATGTTCTCTTGGATA1440
CATCGTAGTGCTGAATTTAATAATATAATTCCTTCATCACAAATTACACAAATACCTTTA1500
ACAAAATCTACTAATCTTGGCTCTGGAACTTCTGTCGTTAAAGGACCAGG ATTTACAGGA1560
GGAGATATTCTTCGAAGAACTTCACCTGGCCAGATTTCAACCTTAAGAGTAAATATTACT1620
GCACCATTATCACAAAGATATCGGGTAAGAATTCGCTACGCTTCTACCACAAATTTACAA1680
TTCCATACATCAATTGACGGAAGACCTA TTAATCAGGGGAATTTTTCAGCAACTATGAGT1740
AGTGGGAGTAATTTACAGTCCGGAAGCTTTAGGACTGTAGGTTTTACTACTCCGTTTAAC1800
TTTTCAAATGGATCAAGTGTATTTACGTTAAGTGCTCATGTCTTCAATTCAGGCAATGAA1860
GTTTA TATAGATCGAATTGAATTTGTTCCGGCAGAAGTAACCTTTGAGGCAGAATATGAT1920
TTAGAAAGAGCACAAAAGGCGGTGAATGAGCTGTTTACTTCTTCCAATCAAATCGGGTTA1980
AAAACAGATGTGACGGATTATCATATTGATCAAGTATCCAATTTAGTTGA GTGTTTATCT2040
GATGAATTTTGTCTGGATGAAAAAAAAGAATTGTCCGAGAAAGTCAAACATGCGAACGAC2100
TTAGTGATGAGCGGAATTTACTTCAAGATCCAAACTTTAGAGGGATCAATAGACAACTAG2160
ACCGTGGCTGGAGAGGAAGTACGGATAT TACCATCCAAGGAGGCGATGACGTATTCAAAG2220
AGAATTACGTTACGCTATTGGGTACCTTTGATGAGTGCTATCCAACGTATTTATATCAAA2280
AAATAGATGAGTCGAAATTAAAAGCCTATACCCGTTACCAATTAAGAGGGTATATCGAAG2340
ATAGT CAAGACTTAGAAATCTATTTAATTCGCTACAATGCCAAACACGAAACAGTAAATG2400
TGCCAGGTACGGGTTCCTTATGGCCGCTTTCAGCCCCAAGTCCAATCGGAAAATGTGCCC2460
ATCATTCCCATCATTTCTCCTTGGACATTGATGTTGGATGTACAGACTTA AATGAGGACT2520
TAGGTGTATGGGTGATATTCAAGATTAAGACGCAAGATGGCCATGCAAGACTAGGAAATC2580
TAGAATTTCTCGAAGAGAAACCATTAGTAGGAGAAGCACTAGCTCGTGTGAAAAGAGCGG2640
AGAAAAAATGGAGAGACAAACGTGAAAA ATTGGAATGGGAAACAAATATTGTTTATAAAG2700
AGGCAAAAGAATCTGTAGATGCTTTATTTGTAAACTCTCAATATGATAGATTACAAGCGG2760
ATACCAACATCGCGATGATTCATGCGGCAGATAAACGCGTTCATAGCATTCGAGA2815
(2) INFORMATION FOR SEQ ID NO:3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 3066 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:
GTTAACACCCTGGGTCAAAAATTGATATTTAGTAAAATTAGTTGCACTTTGTGCATTTTT60
TCA TAAGATGAGTCATATGTTTTAAATTGTAGTAATGAAAAACAGTATTATATCATAATG120
AATTGGTATCTTAATAAAAGAGATGGAGGTAACTTATGGATAACAATCCGAACATCAATG180
AATGCATTCCTTATAATTGTTTAAGTAACCCTGAAGTAGAAGTATTAGG TGGAGAAAGAA240
TAGAAACTGGTTACACCCCAATCGATATTTCCTTGTCGCTAACGCAATTTCTTTTGAGTG300
AATTTGTTCCCGGTGCTGGATTTGTGTTAGGACTAGTTGATATAATATGGGGAATTTTTG360
GTCCCTCTCAATGGGACGCATTTCTT GTACAAATTGAACAGTTAATTAACCAAAGAATAG420
AAGAATTCGCTAGGAACCAAGCCATTTCTAGATTAGAAGGACTAAGCAATCTTTATCAAA480
TTTACGCAGAATCTTTTAGAGAGTGGGAAGCAGATCCTACTAATCCAGCATTAAGAGAAG540
AGA TGCGTATTCAATTCAATGACATGAACAGTGCCCTTACAACCGCTATTCCTCTTTTTG600
CAGTTCAAAATTATCAAGTTCCTCTTTTATCAGTATATGTTCAAGCTGCAAATTTACATT660
TATCAGTTTTGAGAGATGTTTCAGTGTTTGGACAAAGGTGGGGATTTGA TGCCGCGACTA720
TCAATAGTCGTTATAATGATTTAACTAGGCTTATTGGCAACTATACAGATCATGCTGTAC780
GCTGGTACAATACGGGATTAGAGCGTGTATGGGGACCGGATTCTAGAGATTGGATAAGAT840
ATAATCAATTTAGAAGAGAATTAACA CTAACTGTATTAGATATCGTTTCTCTATTTCCGA900
ACTATGATAGTAGAACGTATCCAATTCGAACAGTTTCCCAATTAACAAGAGAAATTTATA960
CAAACCCAGTATTAGAAAATTTTGATGGTAGTTTTCGAGGCTCGGCTCAGGGCATAGAAG1020
GAA GTATTAGGAGTCCACATTTGATGGATATACTTAACAGTATAACCATCTATACGGATG1080
CTCATAGAGGAGAATATTATTGGTCAGGGCATCAAATAATGGCTTCTCCTGTAGGGTTTT1140
CGGGGCCAGAATTCACTTTTCCGCTATATGGAACTATGGGAAATGCAGC TCCACAACAAC1200
GTATTGTTGCTCAACTAGGTCAGGGCGTGTATAGAACATTATCGTCCACTTTATATAGAA1260
GACCTTTTAATATAGGGATAAATAATCAACAACTATCTGTTCTTGACGGGACAGAATTTG1320
CTTATGGAACCTCCTCAAATTTGCCA TCCGCTGTATACAGAAAAAGCGGAACGGTAGATT1380
CGCTGGATGAAATACCGCCACAGAATAACAACGTGCCACCTAGGCAAGGATTTAGTCATC1440
GATTAAGCCATGTTTCAATGTTTCGTTCAGGCTTTAGTAATAGTAGTGTAAGTATAATAA1500
GAG CTCCTATGTTCTCTTGGATACATCGTAGTGCTGAATTTAATAATATAATTCCTTCAT1560
CACAAATTACACAAATACCTTTAACAAAATCTACTAATCTTGGCTCTGGAACTTCTGTCG1620
TTAAAGGACCAGGATTTACAGGAGGAGATATTCTTCGAAGAACTTCACC TGGCCAGATTT1680
CAACCTTAAGAGTAAATATTACTGCACCATTATCACAAAGATATCGGGTAAGAATTCGCT1740
ACGCTTCTACCACAAATTTACAATTCCATACATCAATTGACGGAAGACCTATTAATCAGG1800
GGAATTTTTCAGCAACTATGAGTAGT GGGAGTAATTTACAGTCCGGAAGCTTTAGGACTG1860
TAGGTTTTACTACTCCGTTTAACTTTTCAAATGGATCAAGTGTATTTACGTTAAGTGCTC1920
ATGTCTTCAATTCAGGCAATGAAGTTTATATAGATCGAATTGAATTTGTTCCGGCAGAAG1980
TAA CCTTTGAGGCAGAATATGATTTAGAAAGAGCACAAAAGGCGGTGAATGAGCTGTTTA2040
CTTCTTCCAATCAAATCGGGTTAAAAACAGATGTGACGGATTATCATATTGATCAAGTAT2100
CCAATTTAGTTGAGTGTTTATCAGATGAATTTTGTCTGGATGAAAAACA AGAATTGTCCG2160
AGAAAGTCAAACATGCGAAGCGACTTAGTGATGAGCGGAATTTACTTCAAGATCCAAACT2220
TCAGAGGGATCAATAGACAACTAGACCGTGGCTGGAGAGGAAGTACGGATATTACCATCC2280
AAGGAGGCGATGACGTATTCAAAGAG AATTACGTTACGCTATTGGGTACCTTTGATGAGT2340
GCTATCCAACGTATTTATATCAAAAAATAGATGAGTCGAAATTAAAAGCCTATACCCGTT2400
ATCAATTAAGAGGGTATATCGAAGATAGTCAAGACTTAGAAATCTATTTAATTCGCTACA2460
ATG CAAAACATGAAACAGTAAATGTGCCAGGTACGGGTTCCTTATGGCCGCTTTCAGCCC2520
AAAGTCCAATCGGAAAGTGTGGAGAGCCGAATCGATGCGCGCCACACCTTGAGTGGAATC2580
CTGACTTAGATTGTTCGTGTAGGGATGGAGAAAAGTGTGCCCATCATTC GCATCATTTCT2640
CCTTAGACATTGATGTAGGATGTACAGACTTAAATGAGGACCTAGGTGTATGGGTGATCT2700
TTAAGATTAAGACGCAAGATGGGCACGCAAGACTAGGGAATCTAGAGTTTCTCGAAGAGA2760
AACCATTAGTAGGAGAAGCGCTAGCT CGTGTGAAAAGAGCGGAGAAAAAATGGAGAGACA2820
AACGTGAAAAATTGGAATGGGAAACAAATATCGTTTATAAAGAGGCAAAAGAATCTGTAG2880
ATGCTTTATTTGTAAACTCTCAATATGATCAATTACAAGCGGATACGAATATTGCCATGA2940
TTC ATGCGGCAGATAAACGTGTTCATAGCATTCGAGAAGCTTGGCGTAATCATGGTCATA3000
CCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG3060
CATAAA 3066
(2) INFORMATION FOR SEQ ID NO:4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 969 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:
MetAspAsnAsnProAsnIleAsnGluCysIlePro TyrAsnCysLeu
151015
SerAsnProGluValGluValLeuGlyGlyGluArgIleGluThrGly
2025 30
TyrThrProIleAspIleSerLeuSerLeuThrGlnPheLeuLeuSer
354045
GluPheValProGlyAlaGlyPheValLeuGlyLeuVal AspIleIle
505560
TrpGlyIlePheGlyProSerGlnTrpAspAlaPheLeuValGlnIle
657075 80
GluGlnLeuIleAsnGlnArgIleGluGluPheAlaArgAsnGlnAla
859095
IleSerArgLeuGluGlyLeuSerAsnLeuTyrGlnIle TyrAlaGlu
100105110
SerPheArgGluTrpGluAlaAspProThrAsnProAlaLeuArgGlu
115120 125
GluMetArgIleGlnPheAsnAspMetAsnSerAlaLeuThrThrAla
130135140
IleProLeuLeuAlaValGlnAsnTyrGlnValProLeuLeuSerVal
145150155160
TyrValGlnAlaAlaAsnLeuHisLeuSerValLeuArgAspValSer
165170 175
ValPheGlyGlnArgTrpGlyPheAspAlaAlaThrIleAsnSerArg
180185190
TyrAsnAspLeuThrArgLeuIleGlyAsnTyrThrAspT yrAlaVal
195200205
ArgTrpTyrAsnThrGlyLeuGluArgValTrpGlyProAspSerArg
210215220
AspTrpValArgTyrAsnGlnPheArgArgGluLeuThrLeuThrVal
225230235240
LeuAspIleValAlaLeuPheProAsnTyrAspSerArgArgTy rPro
245250255
IleArgThrValSerGlnLeuThrArgGluIleTyrThrAsnProVal
260265 270
LeuGluAsnPheAspGlySerPheArgGlySerAlaGlnGlyIleGlu
275280285
ArgSerIleArgSerProHisLeuMetAspIleLeuAsnSerIle Thr
290295300
IleTyrThrAspAlaHisArgGlyTyrTyrTyrTrpSerGlyHisGln
305310315320
IleMetAlaSerProValGlyPheSerGlyProGluPheThrPhePro
325330335
LeuTyrGlyThrMetGlyAsnAlaAlaProGlnGlnArgIle ValAla
340345350
GlnLeuGlyGlnGlyValTyrArgThrLeuSerSerThrPheTyrArg
355360365
ArgProPheAsnIleGlyIleAsnAsnGlnGlnLeuSerValLeuAsp
370375380
GlyThrGluPheAlaTyrGlyThrSerSerAsnLeuProSerAlaVal
385390395400
TyrArgLysSerGlyThrValAspSerLeuAspGluIleProProGln
40541041 5
AsnAsnAsnValProProArgGlnGlyPheSerHisArgLeuSerHis
420425430
ValSerMetPheArgSerGlySerSerSerSerValSerIleIl eArg
435440445
AlaProMetPheSerTrpIleHisArgSerAlaGluPheAsnAsnIle
450455460
Ile AlaSerAspSerIleThrGlnIleProAlaValLysGlyAsnPhe
465470475480
LeuPheAsnGlySerValIleSerGlyProGlyPheThrGlyGlyAsp
485490495
LeuValArgLeuAsnSerSerGlyAsnAsnIleGlnAsnArgGlyTyr
500505510
IleGluValProIleHisPheProSerThrSerThrArgTyrArgVal
515520525
ArgValArgTyrAlaSerValThrProIleHisLeuAsnValAsnTrp
530535540
GlyAsnSerSerIlePheSerAsnThrValProAlaThrAlaThrSer
545550555560
LeuAspAsnLeuGlnSerSerAspPheGlyTyrPheGluSerAlaAsn
565570575
AlaPheThrSerSerLeuGlyAsnIleValGlyValArgAsnPheS er
580585590
GlyThrAlaGlyValIleIleAspArgPheGluPheIleProValThr
595600605
AlaThrLeuGluAlaGluTyrAsnLeuGluArgAlaGlnLysAlaVal
610615620
AsnAlaLeuPheThrSerThrAsnGlnLeuGlyLeuLysThrAsnVal
625 630635640
ThrAspTyrHisIleAspGlnValSerAsnLeuValThrTyrLeuSer
645650655
AspGluPheCysLeuAspGluLysArgGluLeuSerGluLysValLys
660665670
HisAlaLysArgLeuSerAspGluArgAsnLeuLeuGlnAspSerAsn
675680685
PheLysAspIleAsnArgGlnProGluArgGlyTrpGlyGlySerThr
690695700
GlyIleT hrIleGlnGlyGlyAspAspValPheLysGluAsnTyrVal
705710715720
ThrLeuSerGlyThrPheAspGluCysTyrProThrTyrLeuTyrGln
725730735
LysIleAspGluSerLysLeuLysAlaPheThrArgTyrGlnLeuArg
740745750
GlyTyrIleGluAspSerGlnAspLeuGluIleTyrLeuIleArgTyr
755760765
AsnAlaLysHisGluThrValAsnValProGlyThrGlySerLeuTrp
770775780
ProLeuSerAlaGlnSerProIleGlyLysCysGlyGluProAsnArg
785790795800
Cys AlaProHisLeuGluTrpAsnProAspLeuAspCysSerCysArg
805810815
AspGlyGluLysCysAlaHisHisSerHisHisPheSerLeuAspIle
820825830
AspValGlyCysThrAspLeuAsnGluAspLeuGlyValTrpValIle
835840845
Phe LysIleLysThrGlnAspGlyHisAlaArgLeuGlyAsnLeuGlu
850855860
PheLeuGluGluLysProLeuValGlyGluAlaLeuAlaArgValLys
865 870875880
ArgAlaGluLysLysTrpArgAspLysArgGluLysLeuGluTrpGlu
885890895
T hrAsnIleValTyrLysGluAlaLysGluSerValAspAlaLeuPhe
900905910
ValAsnSerGlnTyrAspGlnLeuGlnAlaAspThrAsnIleAlaMet
915920925
IleHisAlaAlaAspLysArgValHisSerIleArgGluAlaTrpArg
930935940
AsnHisGlyHi sSerCysPheLeuCysGluIleValIleArgSerGln
945950955960
PheHisThrThrTyrGluProGluAla
965
(2) INFORMATION FOR SEQ ID NO:5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 695 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:
MetAspAsnAsnProAsnIleAsnGluCysIleProTyrAsnCysLeu
1 51015
SerAsnProGluValGluValLeuGlyGlyGluArgIleGluThrGly
202530
TyrThrPr oIleAspIleSerLeuSerLeuThrGlnPheLeuLeuSer
354045
GluPheValProGlyAlaGlyPheValLeuGlyLeuValAspIleIle
50 5560
TrpGlyIlePheGlyProSerGlnTrpAspAlaPheLeuValGlnIle
65707580
GluGlnLeuIleAs nGlnArgIleGluGluPheAlaArgAsnGlnAla
859095
IleSerArgLeuGluGlyLeuSerAsnLeuTyrGlnIleTyrAlaGlu
100105110
SerPheArgGluTrpGluAlaAspProThrAsnProAlaLeuArgGlu
115120125
GluMetArgIleGln PheAsnAspMetAsnSerAlaLeuThrThrAla
130135140
IleProLeuPheAlaValGlnAsnTyrGlnValProLeuLeuSerVal
145150 155160
TyrValGlnAlaAlaAsnLeuHisLeuSerValLeuArgAspValSer
165170175
ValPheGlyGlnA rgTrpGlyPheAspAlaAlaThrIleAsnSerArg
180185190
TyrAsnAspLeuThrArgLeuIleGlyAsnTyrThrAspHisAlaVal
195 200205
ArgTrpTyrAsnThrGlyLeuGluArgValTrpGlyProAspSerArg
210215220
AspTrpIleArgTyrAsnGlnPh eArgArgGluLeuThrLeuThrVal
225230235240
LeuAspIleValSerLeuPheProAsnTyrAspSerArgThrTyrPro
245 250255
IleArgThrValSerGlnLeuThrArgGluIleTyrThrAsnProVal
260265270
LeuGluAsnPheAsp GlySerPheArgGlySerAlaGlnGlyIleGlu
275280285
GlySerIleArgSerProHisLeuMetAspIleLeuAsnSerIleThr
290 295300
IleTyrThrAspAlaHisArgGlyGluTyrTyrTrpSerGlyHisGln
305310315320
IleMetAlaSerProVal GlyPheSerGlyProGluPheThrPhePro
325330335
LeuTyrGlyThrMetGlyAsnAlaAlaProGlnGlnArgIleValAla
340 345350
GlnLeuGlyGlnGlyValTyrArgThrLeuSerSerThrLeuTyrArg
355360365
ArgProPheAsnIleGlyI leAsnAsnGlnGlnLeuSerValLeuAsp
370375380
GlyThrGluPheAlaTyrGlyThrSerSerAsnLeuProSerAlaVal
385390 395400
TyrArgLysSerGlyThrValAspSerLeuAspGluIleProProGln
405410415
AsnAsnAsnValProPr oArgGlnGlyPheSerHisArgLeuSerHis
420425430
ValSerMetPheArgSerGlyPheSerAsnSerSerValSerIleIle
435 440445
ArgAlaProMetPheSerTrpIleHisArgSerAlaGluPheAsnAsn
450455460
IleIleProSerSerGlnIleThrGln IleProLeuThrLysSerThr
465470475480
AsnLeuGlySerGlyThrSerValValLysGlyProGlyPheThrGly
485 490495
GlyAspIleLeuArgArgThrSerProGlyGlnIleSerThrLeuArg
500505510
ValAsnIleThrAlaPro LeuSerGlnArgTyrArgValArgIleArg
515520525
TyrAlaSerThrThrAsnLeuGlnPheHisThrSerIleAspGlyArg
5305 35540
ProIleAsnGlnGlyAsnPheSerAlaThrMetSerSerGlySerAsn
545550555560
LeuGlnSerGlySerPheArgT hrValGlyPheThrThrProPheAsn
565570575
PheSerAsnGlySerSerValPheThrLeuSerAlaHisValPheAsn
580 585590
SerGlyAsnGluValTyrIleAspArgIleGluPheValProAlaGlu
595600605
ValThrPheGluAlaGluTyrAs pLeuGluArgAlaGlnLysAlaVal
610615620
AsnGluLeuPheThrSerSerAsnGlnIleGlyLeuLysThrAspVal
625630 635640
ThrAspTyrHisIleAspGlnValSerAsnLeuValGluCysLeuSer
645650655
AspGluPheCysLeuAspGlu LysLysGluLeuSerGluLysValLys
660665670
HisAlaAsnAspLeuValMetSerGlyIleTyrPheLysIleGlnThr
675 680685
LeuGluGlySerIleAspAsn
690695
(2) INFORMATION FOR SEQ ID NO:6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 969 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
( ii) MOLECULE TYPE: protein
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:
MetAspAsnAsnProAsnIleAsnGluCysIleProTyrAsnCysLeu
151015
SerAsnProGluValGluValLeuGl yGlyGluArgIleGluThrGly
202530
TyrThrProIleAspIleSerLeuSerLeuThrGlnPheLeuLeuSer
3540 45
GluPheValProGlyAlaGlyPheValLeuGlyLeuValAspIleIle
505560
TrpGlyIlePheGlyProSerGlnTrpAspAlaPheLe uValGlnIle
65707580
GluGlnLeuIleAsnGlnArgIleGluGluPheAlaArgAsnGlnAla
8590 95
IleSerArgLeuGluGlyLeuSerAsnLeuTyrGlnIleTyrAlaGlu
100105110
SerPheArgGluTrpGluAlaAspProThrA snProAlaLeuArgGlu
115120125
GluMetArgIleGlnPheAsnAspMetAsnSerAlaLeuThrThrAla
130135 140
IleProLeuPheAlaValGlnAsnTyrGlnValProLeuLeuSerVal
145150155160
TyrValGlnAlaAlaAsnLeuHisLeuSerValLe uArgAspValSer
165170175
ValPheGlyGlnArgTrpGlyPheAspAlaAlaThrIleAsnSerArg
180185 190
TyrAsnAspLeuThrArgLeuIleGlyAsnTyrThrAspHisAlaVal
195200205
ArgTrpTyrAsnThrGlyLeuGluArgValTrpGly ProAspSerArg
210215220
AspTrpIleArgTyrAsnGlnPheArgArgGluLeuThrLeuThrVal
225230235 240
LeuAspIleValSerLeuPheProAsnTyrAspSerArgThrTyrPro
245250255
IleArgThrValSerGlnLeuThrArgGluIle TyrThrAsnProVal
260265270
LeuGluAsnPheAspGlySerPheArgGlySerAlaGlnGlyIleGlu
275280 285
GlySerIleArgSerProHisLeuMetAspIleLeuAsnSerIleThr
290295300
IleTyrThrAspAlaHisArgGlyGluTyrTyrTrpSerGlyH isGln
305310315320
IleMetAlaSerProValGlyPheSerGlyProGluPheThrPhePro
325330 335
LeuTyrGlyThrMetGlyAsnAlaAlaProGlnGlnArgIleValAla
340345350
GlnLeuGlyGlnGlyValTyrArgThrLeuSerSe rThrLeuTyrArg
355360365
ArgProPheAsnIleGlyIleAsnAsnGlnGlnLeuSerValLeuAsp
370375380
GlyThrGluPheAlaTyrGlyThrSerSerAsnLeuProSerAlaVal
385390395400
TyrArgLysSerGlyThrValAspSerLeuAspGluIle ProProGln
405410415
AsnAsnAsnValProProArgGlnGlyPheSerHisArgLeuSerHis
420425 430
ValSerMetPheArgSerGlyPheSerAsnSerSerValSerIleIle
435440445
ArgAlaProMetPheSerTrpIleHisArgSerAlaGlu PheAsnAsn
450455460
IleIleProSerSerGlnIleThrGlnIleProLeuThrLysSerThr
465470475 480
AsnLeuGlySerGlyThrSerValValLysGlyProGlyPheThrGly
485490495
GlyAspIleLeuArgArgThrSerProGlyGlnIleS erThrLeuArg
500505510
ValAsnIleThrAlaProLeuSerGlnArgTyrArgValArgIleArg
515520 525
TyrAlaSerThrThrAsnLeuGlnPheHisThrSerIleAspGlyArg
530535540
ProIleAsnGlnGlyAsnPheSerAlaThrMetSerSerGlySerAs n
545550555560
LeuGlnSerGlySerPheArgThrValGlyPheThrThrProPheAsn
565570 575
PheSerAsnGlySerSerValPheThrLeuSerAlaHisValPheAsn
580585590
SerGlyAsnGluValTyrIleAspArgIleGluPheVal ProAlaGlu
595600605
ValThrPheGluAlaGluTyrAspLeuGluArgAlaGlnLysAlaVal
610615620
AsnGluLeuPheThrSerSerAsnGlnIleGlyLeuLysThrAspVal
625630635640
ThrAspTyrHisIleAspGlnValSerAsnLeuValGluCys LeuSer
645650655
AspGluPheCysLeuAspGluLysGlnGluLeuSerGluLysValLys
660665 670
HisAlaLysArgLeuSerAspGluArgAsnLeuLeuGlnAspProAsn
675680685
PheArgGlyIleAsnArgGlnLeuAspArgGlyTrpArgGlyS erThr
690695700
AspIleThrIleGlnGlyGlyAspAspValPheLysGluAsnTyrVal
70571071572 0
ThrLeuLeuGlyThrPheAspGluCysTyrProThrTyrLeuTyrGln
725730735
LysIleAspGluSerLysLeuLysAlaTyrThrArgTyrGl nLeuArg
740745750
GlyTyrIleGluAspSerGlnAspLeuGluIleTyrLeuIleArgTyr
755760765
AsnAlaLysHisGluThrValAsnValProGlyThrGlySerLeuTrp
770775780
ProLeuSerAlaGlnSerProIleGlyLysCysGlyGluProAsnArg
785790795800
CysAlaProHisLeuGluTrpAsnProAspLeuAspCysSerCysArg
805810 815
AspGlyGluLysCysAlaHisHisSerHisHisPheSerLeuAspIle
820825830
AspValGlyCysThrAspLeuAsnGluAspLeuGlyValTrp ValIle
835840845
PheLysIleLysThrGlnAspGlyHisAlaArgLeuGlyAsnLeuGlu
850855860
Ph eLeuGluGluLysProLeuValGlyGluAlaLeuAlaArgValLys
865870875880
ArgAlaGluLysLysTrpArgAspLysArgGluLysLeuGluTrpG lu
885890895
ThrAsnIleValTyrLysGluAlaLysGluSerValAspAlaLeuPhe
90090591 0
ValAsnSerGlnTyrAspGlnLeuGlnAlaAspThrAsnIleAlaMet
915920925
IleHisAlaAlaAspLysArgValHisSerIleArgGluAlaTrpAr g
930935940
AsnHisGlyHisThrCysPheLeuCysGluIleValIleArgSerGln
945950955960
PheHisThrThrTyrGluProGluAla
965
Claims
1. Recombinant DNA coding for an insecticidally active form of the Bacillus thuringiensis endotoxin comprising DNA derived from a 6.6-type endotoxin gene of the A20 strain of Bacillus thuringiensis.
2. Recombinant DNA as claimed in claim 1 wherein the DNA is chromosomally derived.
3. Recombinant DNA as claimed in claim 1 comprising the first 2910 basepairs (970 amino acid codons) of the N-terminal coding region of a plasmid-derived 6.6-type endotoxin gene from Strain A20.
4. Recombinant DNA as claimed in claim 3 which is derived from the E. coli strain deposited at the NCIMB under the number 40211.
5. Recombinant DNA coding for an insecticidally-active form of the Bacillus thuringiensis endotoxin comprising the first 1692 basepairs (564 amino acid codons) of the amino-terminal coding region from a 5.3-type endotoxin gene derived from Strain A20 and a restriction endonuclease Hind III-generated internal fragment of 1131 basepairs (377 amino acid codons) from a 4.5-type endotoxin gene derived from strain A20.
6. Recombinant DNA as claimed in claim 5 which is derived from the E. coli strain deposited at the NCIMB under the number 40050.
7. Recombinant DNA as claimed in claim 1 or claim 5 comprising a transcriptional initiation region operative in plants and positioned for transcription of the DNA coding for the Bacillus thuringiensis endotoxin.
| 5061489 | October 29, 1991 | Bernier et al. |
| 228838 | July 1987 | EPX |
| 269601 | June 1988 | EPX |
- Chemical Abstracts, vol. 108, No. 21, 23 May 1988. (Columbus, Ohio, US), Hefford, Mary Alice et al: "Sequence of a lepidopteran toxin gene of Bacillus thuringiensis subsp kurstaki NRD-12.", see p. 182, abstract 181175c, & J. Biotechnol. 1987, 6(4), 307-22. Hofte et al., Appl. Env. Microb., vol. 54, No. 8, Aug. 1988, pp. 2010-2017. Prefontaine et al., Appl. Env. Microb, vol. 53, No. 12, Dec. 1987, pp. 2808-2814. Hefford et al., J. Biotech., vol. 6, pp. 307-322, 1987.
Type: Grant
Filed: Apr 1, 1991
Date of Patent: Jun 13, 1995
Assignee: Imperial Chemical Industries PLC (London)
Inventors: Susan Ely (Bucks), Janet M. Tippett (Reading)
Primary Examiner: Robert A. Wax
Assistant Examiner: Keith D. Hendricks
Law Firm: Cushman, Darby & Cushman
Application Number: 7/671,817
International Classification: C12N 1500; C07H 1700; A01N 6300;
